The cross-country recognition honors exceptional medtech companies in Asia who have gone above and beyond to launch initiatives and serve their customers with groundbreaking innovations. This is the first time that Medtronic Singapore and Malaysia are receiving this top accolade at the Healthcare Asia Medtech Awards, while it is the third consecutive year that Medtronic Philippines has been recognized at the awards ceremony.
The company's initiatives that received recognition include the first-in-Medtronic APAC stroke public awareness campaign involving lifestyle influencers, employees, doctors, and patients, through a mix of digital and traditional media channels to reach out to patients and their young caregivers. Medtronic was also acknowledged for its partnership with Southeast Asia's largest cardiac centre, Institut Jantung Negara (IJN), involving joint capacity-building efforts and the set up of a center of excellence to introduce new therapies, clinical research and new initiatives around cardiac and vascular care advancement. At the same time, Medtronic's efforts in continuously introducing innovative technology that help bring about better patient outcomes were recognized through its launch of the advanced hybrid closed-loop system insulin pump in Philippines.
"At Medtronic, we have always worked closely with our partners to improve patient access to healthcare. Our win in the three categories shows how we are working across the entire spectrum of patients, healthcare professionals, hospitals and employees to increase disease knowledge and introduce innovative technologies that can bring help elevate healthcare landscape in Asia Pacific. The recognition is testament to our unwavering commitment to continue supporting patients and alleviate pain, restore health, extend life for the communities that we serve," Jennifer Cho, Vice President & Managing Director, Island Southeast Asia, Medtronic.
Hashtag: #Medtronic
https://www.Medtronic.com
https://www.linkedin.com/company/medtronic
The issuer is solely responsible for the content of this announcement.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated result
